Researchers
Tomašević, Zorica
Results 1-20 of 145
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2023 | Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial | Holmes Frankie A; Moy Beverly; Delaloge Suzette; Chia Stephen KL; Ejlertsen Bent; Mansi Janine; Iwata Hiroji; Gnant Michael; Buyse Marc; Barrios Carlos H;
Silovski Tajana; Šeparović Robert; Bashford Anna; Zotano Guerrero Angel; Dendeluri Neelima; Patt Debra; Gokmen Erhan; Gore Ira; Smith II John W; Loibl Sibylle; Masuda Norikazu; Tomašević Zorica
  ; Petrakova Katarina; DiPrimeo Daniel; Wong Alvin; Martin Miguel; Chan Arlene; ExteNET Study Group; | Article | 21aM21a |
| 2022 | 229P Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS) | Djurmez, Ognjen; Calamac, Marina; Dimitrijevic, M; Vukosavljevic, JG; Serovic, Kristina; Oblakovic-Babic, Jelena S; Stanic, Nemanja S; Minic, Ivana Z ; Tomasevic, Zorica I ; Bozovic-Spasojevic, Ivana M | Conference Paper | Mp. category will be shown later |
| 2022 | Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS) | Djurmez, Ognjen; Calamac, Marina; Dimitrijevic, M; Vukosavljevic, JG; Serovic, Kristina; Oblakovic-Babic, Jelena S; Stanic, Nemanja S; Minic, Ivana Z; Tomasevic, Zorica I ; Bozovic-Spasojevic, Ivana M | Conference Paper | Mp. category will be shown later |
| 2021 | White blood cell subsets in HER2-positive breast cancer patients treated with trastuzumab in relation to clinical outcome | Matić Ivana Z ; Grujić Milica; Kolundžija Branka; Damjanović Ana ; Tomašević Zorica ; Crnogorac Marija Đ ; Dzodic Radan ; Filipović Ivana Lj ; Ždrale Zdravko; Erić-Nikolić Aleksandra ;
Juranić Zorica
; | Article | 21M21 |
| 2020 | Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study | Kolberg, Hans-Christian; Colleoni, Marco A; Sawa-Demetriou, G; Santi, Patricia Xavier; Tesch, Hans; Fujiwara, Yasuhiro; Tomasevic, Zorica I ; Hanes, Vladimir | Article | 21aM21a |
| 2020 | Incidence of non-breast cancer neoplasms (non-BCN) diagnosed prior and subsequent to breast cancer (BC): Single institution experience. | Tomasevic, Zorica I ; Tomasevic, Zoran M ; Grujicic, Danica M ; Nikitovic, Marina R ; Milovanovic, Zorka M | Conference Paper | Mp. category will be shown later |
| 2019 | Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia | Krivokuća, Ana ; Boljević, Ivana ; Jovandic, Stevo; Magic, Zvonko ; Mandić, Aljoša ; Tomasevic, Zorica ; Brankovic-Magic, Mirjana | Article | 21M21 |
| 2019 | Breast cancer and recurrent thrombosis - Results from prospective single center study | Kovač, Mirjana ; Kovac, Zeljko; Tomasević, Zorica ; Tomić, Branko ; Gvozdenov, Maja ; Radojković, Dragica | Contribution to periodical | 22M22 |
| 2019 | AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan) | Todorovic, Vladimir; ...; Babovic, Nada Lj; ...; Četniković, Bojana; Ceric, Timur; ...; Dzamic, Zoran M ; Dzodic, Radan R ; Eri, Živka ;
...; Knežević-Ušaj, Slavica F
; Kovcin, Vladimir N; ...; Markovic, Ivan Z; Markovic, Milan; Mijalkovic, Nenad; ...; Pantelic, Aleksandra; Popović, Lazar S ; Radosavljevic, Davorin Z; ...; Radulovic, Sinisa S; ...; Rosic, Ivana; ...; Stamatović, Ljiljana ; ...; Tesanovic, Dusanka D; Tomasevic, Zorica I ; Tomasevic, Zoran M; ...; Vasovic, Suzana; Vicko, Ferenc ; ...; Zarić, Bojan ; ...; (broj, koautora 65); | Article | 23M23 |
| 2018 | Abstract PD3-10: Safety results from a randomized, double-blind, phase 3 study of ABP 980 compared with trastuzumab in patients with breast cancer | Kolberg, Hans-Christian; Demetriou, Georgia S; Zhang, Nan; Tomasevic, Zorica I ; Hanes, Vladimir | Conference Paper | Mp. category will be shown later |
| 2018 | Paclitaxel-induced peripheral neuropathy in patients with operable breast cancer | Serovic, Kristina; Tomasevic, Zoran M ; Bozovic-Spasojevic, Ivana M ; Minic, Ivana Z ; Oblakovic-Babic, Jelena S; Jokic, Vladimir; Pusica, Aleksandra; Tomasevic, Zorica I | Conference Paper | Mp. category will be shown later |
| 2018 | Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE | Popović, Lazar ; Tomašević, Zorica ; Stamatović, Ljiljana ; Marković, Ivan ; Matovina-Brko, Gorana ; Buta, Marko ; Golubović, Andrija ; Selaković, Vladimir; Trifunović, Jasna ; Mutrezani, Zafir;
Ivanović, Nebojša
; Nedović, Jasmina; Ninković, Srđan ; Filipović, Slađana; Cvetanović, Ana ; Đorđević, Nebojša; Karanikolić, Aleksandar ; Ivković-Kapicl, Tatjana ; Vicko, Ferenc ; | Article | 23M23 |
| 2018 | Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial | von, Minckwitz Gunter; Colleoni, Marco A; Kolberg, Hans-Christian; Morales, Serafin; Santi, Patricia Xavier; Tomasevic, Zorica I ; Zhang, Nan; Hanes, Vladimir | Article | 21a+M21a+ |
| 2017 | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Group | M. Miguel; F. Holmes; B. Ejlertsen; S. Delaloge; B. Moy; H. Iwata; G. von Minckwitz; S. Chia; J. Mansi; C. Barrios;
Tomašević, Zorica I.
; M. Gnant...et al.; ExteNET Study Group; | Article | 21a+M21a+ |
| 2017 | Cerebellar metastases as the only brain metastatic site and correlation with molecular characteristics of primary breast cancer. | Tomašević, Zorica I. ; Tomasevic Zoran ; Grujicic Danica ; Z. Kovac; Milovanovic Z.orka ; Minic Ivana ; Kolarevic Daniela | Conference Paper | Mp. category will be shown later |
| 2017 | Preporuke za praćenje bolesnica sa ranim karcinomom dojke;vodiči i svakodnevna klinička praksa | Tomašević, Zorica I. | Conference Paper | Mp. category will be shown later |
| 2017 | Biosimilari u onkologiji bazirano na ESMO position paper | Tomašević, Zorica I. | Conference Paper | Mp. category will be shown later |
| 2017 | Prognostic importance of steroid receptor status for disease free and overall survival after surgical resection of isolated liver metastasis in breast cancer patients | Zegarac, Milan ; Nikolic. Srdjan ; Gavrilovic, Dusica; Kolarevic, Daniela ; Jevric, Marko ; Nikolic-Tomasevic, Zorica ; Kocic, Milan; Djurisic Igor ; Inic, Zorka; Markovic, Ivan ;
Buta, Marko
; Ninkovic, Srdjan; Dzodic, Radan ; | Article | 23M23 |
| 2017 | Characteristics of HER2 3+ metastatic breast cancer patients with long-term benefit of trastuzumab. | Tomašević, Zorica I. ; Tomašević, Zoran ; Minić, Ivana ; Kolarević, Daniela | Conference Paper | Mp. category will be shown later |
| 2016 | High Factor VIII and advanced disease are associated with risk of recurrent thrombosis in women with breast cancer | Tomašević, Zorica ; Kovac MK ; Kovac Z; Pruner I ; Tomic BV ; Djordjevic VJ ; Radojkovic DP | Conference Paper | Mp. category will be shown later |